TABLE 3

Univariate Survival Analysis for 31 Patients with Evaluable Response After Neoadjuvant Therapy

ParameterP
ER expression0.48
c-erbB-2 expression0.98
Ki-67 proliferative index0.21
Pathologic response0.34
>4 positive nodes after therapy0.004
MRFDG (PET)0.14
Blood flow (PET)0.69
MRFDG/flow (PET)0.05
  • Median follow-up = 32.5 mo.